Bay Area based Multiply Labs gave BiotechTV a behind the scenes look at the state of the art robotics that are being used today to manufacture advanced biologics and other modalities
CEO Fred Parietti described how robotics is changing the manufacturing process, which up to this point have been significantly done in part by hand. He believes it is a sneak peek at the factory of the future.
1 hour ago
Formation Bio announced a $600M fund it will use to acquire 10–15 drug programs over the next 3–5 years - it is a step in its plan to make drug development more efficient and become 'the next pharma'
Co-Founder and CEO Ben Liu describes the fund, and explains why Formation chose this structure rather than doing an equity raise. He also explains Formation's approach to drug development, the types of assets it likes to look for, why a smaller company might be more nimble than larger pharmas today, and the Formation's lofty long-term ambitions.
23 hours ago
Mizuho Senior Biotech Analyst Graig Suvannavejh gives his take on biotech's pause and discusses companies he covers with key items in the news
He discusses Belite Bio, Tarsus, Alkermes, Palvella, Corvus, and more. Chapters General sentiment - 1:35 Belite Bio - 2:48 Tarsus - 5:50 Alkermes - 8:25 Palvella - 12:08 Corvus - 14:35
1 day ago
.png){kind=logo}
